New oxygen device may make endoscopy safer for High-Risk patients

NCT ID NCT07439822

ENROLLING_BY_INVITATION Symptom relief Sponsor: Outcomes'10 Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether high-flow oxygen therapy can prevent low oxygen levels (hypoxemia) in patients at higher risk during sedated digestive endoscopy. The trial includes 326 adults with obesity, sleep apnea, or stable lung or heart conditions. Researchers will compare high-flow oxygen with standard low-flow nasal cannulas to see which is safer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
high-flow medical oxygen insufflation
What this could lead to
If it works, this could make digestive endoscopy safer for patients with obesity, sleep apnea, or lung disease by reducing dangerous drops in oxygen levels.
What could go wrong
This is a phase 4 study, so the intervention is already in use; however, it may not show a clear benefit over standard low-flow oxygen, and results may not apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOXEMIA DURING SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Universitario Río Hortega

    Valladolid, Valladolid, 47012, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.